Home
overview

What is this event about?

 

    

About the conference

SMi is proud to present their 6th annual Pharmaceutical Parallel Trade Conference . This year's event will bring together expert speakers from different sectors within the industry, each with differing opinions and perspectives to offer. In such a rapidly developing field of parallel trade, it is essential that companies are kept up to date with the latest developments, regulations and strategies.

With the growth of parallel trade of pharmaceuticals in the European Union increasing consistently (despite numerous challenges from some of the industry’s biggest players) this event is more relevant than ever. The principles of free movement of goods and the regional exhaustion of intellectual property rights, as well as the European Court of Justice consistently ruling in their favour on cases relating to trademark issues have led to great financial succes for parallel traders. In response, pharmaceutical companies are now looking towards new solutions and strategies to address parallel trade, leading case studies of which will be discussed and presented at the 2012 conference.

Interested in shaping the agenda or speaking at the conference?

Please email smiproduction@smi-online.co.uk for more information on how you can get involved.

Interested in sponsoring or exhibiting?

SMi offer a variety of sponsorship, exhibition, advertising and branding packages,uniquely tailored to complement your company’s marketing strategy. Prime Networking opportunities exist to entertain, enhance and expand your client base within the context of an independent discussion specific to your industry. Should you wish to join the increasing number of companies benefiting from sponsoring our conferences, please contact emailing sponsorshipdept@smi-online.co.uk 

 

 

 

Hear about new techniques, strategies and developments in the field of parallel trade
Understand the European directives and regulations
Discuss risks that counterfeiting and repackaging in parallel trade may pose to patient safety
Learn from multiple case studies demonstrating real life data and processes that work
Develop strategies and techniques to limit the concerns and issues associated with parallel trade
Network with key industry associates and solution providers to share valuable experiences

 

Heads of Department, Directors, Managers and Partners from the following departments:

• Pricing
• Market access
• Health technology assessment
• Supply chain management 
• Legal affairs
• Intellectual property
• Health Economics
• Distribution
• Portfolio management
• Anti-counterfeiting
• Intellectual property
• Competition law
• Health economics
• Packaging
• Reimbursement

 

 

 

 

Delegates at our 2011 Parallel Trade conference came from across the world... Join the wide range of high-level delegates at our event in 2011..

     

 Previous attendees and participants have come from organizations including: 

  • Merck and Co
  • Astrazeneca
  • Roche
  • GSK
  • Abbott
  • Boehringer-Ingelheim
  • Novo Nordisk
  • Lundbeck
  • Novartis
  • Office of Health Economics
  • Mölnlycke Health Care
  • Norgline
  • Johnson and Johnson
  • Gilead Sciences
  • Biogen Idec
  • Standing Committee of European Doctors
  • Elan Pharma
  • Arnold & Porter LLP
  • Janssen
  • Belupo
  • Kantar Health
  • Kohlpharma
  • Amarant
  • Cellgene
  • ABPI
  • Europe Economics
  • Biophausia
  • Latham & Watkins LLP
  • Pliva
  • European Training and Stimulation Association
  • Stelerix
  • Clarity Pharma
  • Orasure Technology
  • University of Ferrera
  • Community Pharmacy Scotland

 

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Jim Thomson

Jim Thomson, Chair, European Alliance for Access to Safe Medicines

9:10 Improving patient safety with EAASM online projects

Jim Thomson

Jim Thomson, Chair, European Alliance for Access to Safe Medicines

o Overview of the novel EAASM projects
o What is to be gained from these developments
o The virtual project’s effects on parallel trade and patient safety

9:50 Why parallel trade exists? A trader´s point of view

Antonio Mendonca Alves

Antonio Mendonca Alves, CEO, MD Pharma SA

o Benefits to the patient
o How effective can parallel trade be within the EU
o Possible solutions to parallel trade disagreements

10:30 Morning Coffee

10:50 Parallel Trade: the third legitimate player on the market

Malgorzata Suska

Malgorzata Suska, Communication & Public Affairs Manager, Delfarma

Polish pharmaceutical market
PI competitive results and savings
PI in Polish law
The future of parallel trade

11:30 Perception of the parallel trade of pharamceuticals in Poland

Izabela Baran-Lewandowska

Izabela Baran-Lewandowska, Post-Doctoral Researcher, University of Southern Denmark

Results of national market research targeted at consumers and pharmacists: community and hospital
Aims of the research
Methodologies used in the study
Results of surveys
Conclusions

12:10 Access to medicines – balancing patient safety and drug supply

Birgit Beger

Birgit Beger, Secretary-General, Standing Committee of European Doctors (CPME)

o Advance harmonisation and increase transparency in pharmaceutical sales
o Combating counterfeit medicines
o Revision of European Commission’s guidelines on good distribution practice
o Access to medicines – a project run by the European Commission with key stakeholders from industry, healthcare professionals and patients

12:50 Networking Lunch

14:00 KEYNOTE ADDRESS: Product and patient safety in parallel distribution

Heinz Kobelt

Heinz Kobelt, Director European Affairs, European Association of Euro-Pharmaceutical Companies

o Regulatory framework and practice ensuring product safety in parallel distribution
o EAEPC initiatives to enhance supply chain safety
o Tackling the issues resulting from the EU directive on falsified medicines – authentication/verification; parallel importers (repackagers) as part of a coding system

14:40 The new EU directive on counterfeit medicines and its effects on parallel trade

Peter Bogaert

Peter Bogaert, Managing Partner, Covington & Burling

o How to interpret the EU directive
o Efficiency and enforceability of the directive
o Evaluating the effects and timeframes for implementation
o Considering how best to follow directions to the benefit of consumers and producers

15:20 Afternoon Tea

15:40 PANEL DISCUSSION: Safety Issues Associated with Parallel Trade

o How parallel trade can affect safety issues?
o Can parallel imports have a positive influence on patient safety?
o Repackaging and anti-counterfeiting strategies

Janice Haigh

Janice Haigh, European Price & Trade Director, Quintiles

Heinz Kobelt

Heinz Kobelt, Director European Affairs, European Association of Euro-Pharmaceutical Companies

Jim Thomson

Jim Thomson, Chair, European Alliance for Access to Safe Medicines

16:20 Intellectual property: patents and trade marks

Christopher Stothers

Christopher Stothers, Partner, Arnold and Porter (UK) LLP

o Patents and the specific mechanism
o Trademarks and repackaging
o Transit of pharmaceuticals through the EU
o Practical experience

17:00 Chairman’s Closing Remarks and Close of Day One

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Eric Noehrenberg

Eric Noehrenberg, Director, Shire Pharmaceuticals

9:10 Rational pricing strategies for patent-holders in face of parallel trade

Dermot Glynn

Dermot Glynn, Chairman, Europe Economics

o Profit-maximising pricing in
  Differentiated national markets 
  A single EU market
o Effects of different international pricing strategies on 
  Patient access
  Profits
  Parallel imports
o Recommendations
 

9:50 The pharmaceutical industry’s response to parallel trade:

Fabrizio Gianfrate

Fabrizio Gianfrate, Professor of Health Economics, University of Ferrara

o Impact of parallel trade on pharmaceutical industry
o The long term effects of parallel trade on R & D investment
o The countermeasures of pharmaceutical industries
o Evolution and next scenarios of strategies

10:30 Morning Coffee

11:00 Competition laws affecting parallel trade restrictions

Cormac Little

Cormac Little, Head of Competition and Regulation Unit, William Fry Solicitors

o Recent developments in EU competition law as it affects parallel trade
o Impact of the financial crisis and completion law analysis
o Current and future EU policy on parallel trade
o Strategies for rights owners
 

11:40 GS1 Standards: Foundational to the EU supply chain

Janice Kite

Janice Kite, Work Team Facilitator, GS1

o It’s not just the EU!
o GS1 standards for healthcare: process and technical standards
o The move to implementation
o How GS1 Standarads assist in compliance to the Falsified Medicines Directive
o Source of risks in repackaging; how to prevent and eliminate dangers

12:20 Networking Lunch

13:40 KEYNOTE ADDRESS: Supply management strategies – a case study approach

Janice Haigh

Janice Haigh, European Price & Trade Director, Quintiles

o Why does supply management work?
o What are the challenges and pitfalls?
o Some examples of good process
 

14:20 Supply quota consequences in community pharmacies

Jan Depoorter

Jan Depoorter, Secretary General, Association of Belgian Pharmacists

o Current issues in community pharmacies with urgent patient demand for products
o Evaluating the supply quota issues
o A possible solution; Belgian Web Tools

15:00 Parallel Trade: A summary

Eric Noehrenberg

Eric Noehrenberg, Director, Shire Pharmaceuticals

o What have we learnt so far?
o Evaluating parallel trade as a catalyst to increasing competition
o How can we move forward? 

15:40 Afternoon Tea

16:00 Close of Day Two

+

Workshops

Parallel Trade, Counterfeiting, and Impact on Public Health
Workshop

Parallel Trade, Counterfeiting, and Impact on Public Health

Copthorne Tara Hotel
8th February 2012
London, United Kingdom

Abolishing Parallel Trade in the Pharmaceutical Industry –Why and How?
Workshop

Abolishing Parallel Trade in the Pharmaceutical Industry –Why and How?

Copthorne Tara Hotel
8th February 2012
London, United Kingdom

Copthorne Tara Hotel

Scarsdale Place
Kensington
London W8 5SR
United Kingdom

Copthorne Tara Hotel

The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

 

HOTEL BOOKING FORM

Title

SubTitle
speaker image

Content


Title


Description

Download


WHAT IS CPD?

CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

CPD AND PROFESSIONAL INSTITUTES

There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

GLOBAL CPD

Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

Event Title

Headline

Text
Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event

SIGN UP OR LOGIN

Sign up
Forgotten Password?

Contact SMi GROUP LTD

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
Registered in England No: 3779287 VAT No: GB 976 2951 71




Forgotten Password

Please enter the email address you registered with. We will email you a new password.